Lung Cancer in Argentina: A Modelling Study of Disease and Economic Burden
Clicks: 73
ID: 283596
2023
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
21.6
/100
73 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #268 of 803 articles by views in arXiv
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 803 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objectives: Lung cancer remains a significant global public health challenge
and is still one of the leading cause of cancer-related death in Argentina.
This study aims to assess the disease and economic burden of lung cancer in the
country.
Study design: Burden of disease study
Methods. A mathematical model was developed to estimate the disease burden
and direct medical cost attributable to lung cancer. Epidemiological parameters
were obtained from local statistics, the Global Cancer Observatory, the Global
Burden of Disease databases, and a literature review. Direct medical costs were
estimated through micro-costing. Costs were expressed in US dollars (US$),
April 2023 (1 US$ =216.38 argentine pesos). A second-order Monte Carlo
simulation was performed to estimate the uncertainty.
Results: Considering approximately 10,000 deaths, 12,000 incident cases, and
14,000 5-year prevalent cases, the economic burden of lung cancer in Argentina
in 2023 was estimated to be US$ 556.20 million (396.96 -718.20), approximately
1.4% of the total healthcare expenditure for the country. The cost increased
with a higher stage of the disease and the main driver was the drug acquisition
(80%). 179,046 Disability-adjusted life years could be attributable to lung
cancer representing the 10% of the total cancer.
Conclusion: The disease and economic burden of lung cancer in Argentina
implies a high cost for the health system and would represent 19% of the
previously estimated economic burden for 29 cancers in Argentina.
| Reference Key |
espinola2023lung
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Andrea Alcaraz; Federico Rodriguez Cairoli; Carla Colaci; Constanza Silvestrini; Carolina Gabay; Natalia Espinola |
| Journal | arXiv |
| Year | 2023 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.